Atellica CH Ca 11097595
by Siemens Healthcare Diagnostics Inc.
Ref 11097595Model IVDR_67_TTN_DUB-C_B_REAG_CA_c
Atellica CH Ca 11097595 is an in vitro diagnostic device (EU IVDR Class B; FDA Class II; FDA product code CIC, Cresolphthalein Complexone, Calcium) made by Siemens Healthcare Diagnostics Inc., registered in EUDAMED on 15 Jul 2026 (Basic UDI-DI 0405686901672VZ), cleared under FDA 510(k) K991576 on 30 Jun 1999 and listed in FDA GUDID since 21 Dec 2017 (UDI-DI 00630414595672), active as of 23 Oct 2026.
Active
Valid until
No date given
FDA recalls
1 ongoingTrust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/IVDR EUDAMED | Number0405686901672VZ 00630414595672 | Date15 Jul 2026 | StatusActive |
| United States | GUDID listing GUDID | Number00630414595672 | Date21 Dec 2017 | StatusListed |
| United States | FDA 510(k)SESE GUDID | NumberK991576 | Date30 Jun 1999 | StatusActive |
Official records
- EUDAMED public site 0405686901672VZ
- AccessGUDID record 00630414595672
- FDA 510(k) database K991576
Across registries
- EUDAMED Basic UDI-DI 0405686901672VZ registered 15 Jul 2026 Active
- FDA 510(k) K991576 decided 30 Jun 1999 Active
- FDA GUDID UDI-DI 00630414595672 listed 21 Dec 2017 Listed
Recalls
-
- Ongoing Z-1498-2022
Falsely Elevated Atellica CH Microalbumin_2 (ALB_2) Results due to Reagent Carryover from the Iron_2 Assay. This defect occurs only when a microalbumin test is run immediately after an iron test.
-
- Terminated Z-2062-2018
Urea Nitrogen reagent kit demonstrated an increased incidence of Calibration Failures. Results cannot be generated by the system when calibration fails.
-
- Terminated Z-1658-2016
Siemens Healthcare Diagnostics has become aware of N-Acetylcysteine (NAC) and Metamizole (Dipyrone) interference with Trinder and Trinder-like reaction assays. Siemens has confirmed that falsely depressed results may occur on samples drawn from patients receiving N-Acetylcysteine (NAC) or Metamizole. NAC is the accepted antidote for acetaminophen toxicity and is justified in patients at signific
Timeline
- Cleared FDA 510(k) K991576
- Recall initiated FDA recalls Z-1658-2016
- Listed FDA GUDID 00630414595672
- Recall initiated FDA recalls Z-2062-2018
- Recall initiated FDA recalls Z-1498-2022
- Registered EUDAMED 0405686901672VZ
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- European Union
- United States
Specification
- Trade name
- Atellica CH Calcium (Ca) EUDAMEDAtellica CH Ca GUDID
- Generic name
- Calcium (Ca2+) IVD, kit, spectrophotometry
- Device name
- IVDR_67_TTN_DUB-C_B_REAG_CA_c
- Model / Ref / Catalog
- 11097595, IVDR_67_TTN_DUB-C_B_REAG_CA_c
- Primary DI / UDI-DI
- 00630414595672
- Basic UDI-DI
- 0405686901672VZ
- 510(k) Number
- FDA product code
- CIC
- EMDN code
- W01010303 Calcium
- GMDN term
- Calcium (Ca2+) IVD, kit, spectrophotometry
- Device class
- Class B EUDAMEDClass II GUDID
- Regulation number
- 862.1145
- EU registration type
- Standard device
- EU market of registration
- Germany
- GUDID distribution status
- In Commercial Distribution
Truth per registry
| Field | EUDAMED | GUDID |
|---|---|---|
| Device class | Class B | Class II |
Similar devices in this category
Other devices filed under CALCIUM.
- Calcium (Ca) Assay Kit (Arsenazo III Method) 153H20TSC by YHLO BIOTECH (NANJING) CO., LTD.
- Atellica CH Calcium_2 (CA_2) 11645760 by Siemens Healthcare Diagnostics
- CALCIUM 1415-0200 by Medicon Hellas SA
- Calcium Arsenazo III D-611 004 by Kalians Corporation
- ABX Pentra Calcium AS CP A11A01954 by Horiba Abx
- CALCIUM ARSENAZO CALA-0250 by VITALSCIENTIFIC
- ARCHITECT 3L79-32 03L7932 by Abbott
- Calcium 981953 by Thermo Fisher Scientific Oy